MicroRNAs in resolution of acute inflammation: identification of novel resolvin Dl‐miRNA circuits
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Mechanisms controlling resolution of acute inflammation are of wide interest. Here, we investigated microRNAs (miRNAs) in self‐limited acute inflammatory exudates and their regulation by resolvin D1 (RvD1). Using real‐time PCR analysis, we found in resolving exudates that miR‐21, miR‐146b, miR‐208a, miR‐203, miR‐142, miR‐302d, and miR‐219 were selectively regulated ( P <0.05) in self‐limited murine peritonitis. RvD1 (300 ng/mouse or 15 µgkg ‐1 ) reduced zymosan‐elicited neutrophil infiltration into the peritoneum 25–50% and shortened the resolution interval (ß i )by ~4 h. In peritonitis at 12 h, RvD1 up‐regulated miR‐21, miR‐146b, and miR‐219 and down‐regulated miR‐208a in vivo. In human macrophages overexpressing recombinant RvD1 receptors ALX/FPR2 or GPR32, these same miRNAs were significantly regulated ( P <0.05) by RvD1 at concentrations as low as 10 nM, recapitulating the in vivo circuit. In addition, RvD1‐miRNAs identified herein target cytokines and proteins involved in the immune system, e.g. , miR‐146b targeted NF‐κB signaling, and miR‐219 targeted 5‐lipoxygenase and reduced leukotriene production. RvD1 also reduced nuclear translocation of NF‐κB and SMAD and down‐regulated phospho‐IκB. Taken together, these results indicate that resolvin‐regulated specific miR‐NAs target genes involved in resolution and establish a novel resolution circuit involving RvD1 receptor‐dependent regulation of specific miRNAs.—Recchiuti, A., Krishnamoorthy, S., Fredman, G., Chiang, N., and Serhan, C. N. MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1‐miRNA circuits. FASEB J. 25, 544–560 (2011). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Naga Prasad, S. V., Duan, Z.-H., Gupta, M. K., Surampudi, V. S. K., Volinia, S., Calin, G. A., Liu, C.-G., Kotwal, A., Moravec, C. S., Starling, R. C., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.036541 · Cited by 140
RetractedAnalysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · cited 1×
“Interestingly, the endonuclease Dicer, which is critical for processing precursors pri-miRNA into mature hairpin miRNAs (27), also binds 5-LO via its C-terminal domain.”
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · cited 1×
“mation, cancer (10), and atherosclerosis (11).”
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
Samuelsson, B. (1983) · Science · doi:10.1126/science.6301011 · Cited by 2,843
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233 · cited 1×
“miRNA 219 down-regulates 5-LO, an essential enzyme involved in the biosynthesis of both leukotrienes and lipoxins (44), as well as D-series resolvins from DHA (15).”
BackgroundSelf-citationNathan, C., & Ding, A. (2010) · Cell · doi:10.1016/j.cell.2010.02.029 · Cited by 2,183
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · cited 7×
“miRNA 219 down-regulates 5-LO, an essential enzyme involved in the biosynthesis of both leukotrienes and lipoxins (44), as well as D-series resolvins from DHA (15).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 1
- 23. Majno G., Cotran R. S., Kaufman N., eds (1982) Current Topics in Inflammation and Infection, Vol. 23, Williams & Wilkins, Baltimore [Google Scholar]
Cited by
Items 101–200 of 292
Roles of resolvins in the resolution of acute inflammation
Qu, Q., Xuan, W., & Fan, G.-H. (2014) · Cell Biology International · doi:10.1002/cbin.10345 · Cited by 65
“Given the involvement of miRNAs in inflammation (Sheedy et al., 2010; Recchiuti et al., 2011; Fredman et al., 2012), regulation of miRNA may be one of the mechanisms underlying the inflammation-resolution effect of resolvins.”
BackgroundQuan-Xin, F., Fan, F., Feng, X., Li, S., Wang, S., Zhao-Xu, L., Xu-Jie, Z., Zhao, Q., & Wang, W. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-148 · Cited by 55
“Recent studies suggested that resolvin D1 (7S,8R,17S-trihydroxy-4Z,9E,11E,13Z,15E,19Zdocosahexaenoic acid, RvD1) exhibited potent antiinflammatory actions in rodent models of inflammation [7].”
BackgroundBiological Roles of Resolvins and Related Substances in the Resolution of Pain
Lim, J. Y., Park, C., & Hwang, S. W. (2015) · BioMed Research International · doi:10.1155/2015/830930 · Cited by 61
Zhang, X., Wang, T., Gui, P., Yao, C., Sun, W., Wang, L., Wang, H., Xie, W., Yao, S., Lin, Y., et al. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/185715 · Cited by 56
“Interestingly, RvD1 significantly reduces tumor necrosis factor (TNF)-α induced phosphorylation of IκB, a critical regulator of NF-κB activation and nuclear translocation in human monocytes [15].”
BackgroundResolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p
Cheng, T., Ding, S., Liu, S., Li, X., Tang, X., & Sun, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.668760 · Cited by 55
Marques-Rocha, J. L., Garcia-Lacarte, M., Samblas, M., Bressan, J., Martínez, J. A., & Milagro, F. I. (2018) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-018-0629-x · Cited by 58
MicroRNAs as new players in the pain game
Niederberger, E., Kynast, K., Lötsch, J., & Geisslinger, G. (2011) · Pain · doi:10.1016/j.pain.2011.01.042 · Cited by 53
“In a murine peritonitis model of self-limiting acute inflammation, miRNAs (miR-21, miR-146b, miR-208a, miR-203, miR-142, miR-302d, and miR-219) could be counter-regulated by administration of resolvin D1, an antiinflammatory lipid mediator [26].”
Resolvin D1 and its GPCRs in resolution circuits of inflammation
Recchiuti, A. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.02.004 · Cited by 59
Self-citationQi, W., Li, H., Cai, X., Gu, J.-Q., Meng, J., Xie, H.-Q., Zhang, J., Chen, J., Jin, X.-G., Tang, Q., et al. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.109 · Cited by 53
Bourdon, J. A., Saber, A. T., Halappanavar, S., Jackson, P. A., Wu, D., Hougaard, K. S., Jacobsen, N. R., Williams, A., Vogel, U., Wallin, H., et al. (2012) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21706 · Cited by 51
“Both miR-146b and miR-21 are associated with resolution of acute inflammation [Recchiuti et al., 2011].”
BackgroundMcCarty, M. F., & Lerner, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103624 · Cited by 51
Kahnt, A. S., Häfner, A., & Steinhilber, D. (2024) · Oncogene · doi:10.1038/s41388-024-03016-1 · Cited by 54
“…5-LO and other proteins in the ARA cascade are also targets of miRNAs and can be regulated by them. miR-674-5p seems to have a negative regulating effect on 5-LO expression in concanavalin A-induced autoimmune reactions in mouse liver [38] whereas miR-219 down-regulates 5-LO in macrophages [39].”
BackgroundHiram, R., Rizcallah, E., Marouan, S., Sirois, C., Sirois, M., Morin, C., Fortin, S., & Rousseau, É. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00177.2015 · Cited by 58
Pahlavani, M., Ramalho, T., Koboziev, I., LeMieux, M. J., Jayarathne, S., Ramalingam, L., Filgueiras, L. R., & Moustaid-Moussa, N. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000535 · Cited by 49
Zheng, S., Wang, Q., D’Souza, V., Bartis, D., Dancer, R. C. A., Parekh, D., Gao, F., Lian, Q., Jin, S., & THICKETT, D. R. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.114 · Cited by 55
Wang, T., Chen, D., Wang, P., Xu, Z., & Li, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.050 · Cited by 48
Recchiuti, A., Codagnone, M., Pierdomenico, A. M., Rossi, C., Mari, V. C., Cianci, E., Simiele, F., Gatta, V., & Romano, M. (2014) · The FASEB Journal · doi:10.1096/fj.13-248393 · Cited by 53
“Interestingly, potency and effective dose range of oral RvD1 are comparable to those reported for intravenously or topically delivered RvD1 (23, 30) or for oral native LXs and LX-stable analogs (15, 16).”
BackgroundSelf-citationMaisto, R., Trotta, M. C., Petrillo, F., Izzo, S., Cuomo, G., Alfano, R., Hermenean, A. O., Barcia, J. M., Galdiero, M., Platania, C. B. M., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00235 · Cited by 49
“The FPR2 receptor represents a bridge between all the RvD1 actions on the inflammation, gene regulation and microvascular damages in diabetic retinopathy rats (Recchiuti et al., 2011; Recchiuti and Serhan, 2012; Yin et al., 2017; Bisicchia et al., 2018).”
BackgroundMicroRNA-147b Regulates Vascular Endothelial Barrier Function by Targeting ADAM15 Expression
Chatterjee, V., Beard, R. S., Reynolds, J. J., Haines, R. J., Guo, M., Rubin, M., Guido, J., Wu, M. H., & Yuan, S. Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110286 · Cited by 48
“Recent studies have shown that miRs are selectively regulated during different phases of inflammation where miRs suppress pro-inflammatory cytokines and chemokines, Toll-like receptors (TLRs), and transcription factors [51–53].”
BackgroundPierdomenico, A. M., Recchiuti, A., Simiele, F., Codagnone, M., Mari, V. C., Davì, G., & Romano, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.592352 · Cited by 47
“Because macrophage phagocytosis is the hallmark of resolution and it is strongly enhanced by pro-resolving lipid mediators, such as LX and Rv (9, 15, 16), we assessed phagocytosis of fluorescent-labeled zymosan particles, which mimics bacterial clearance from inflamed tissue, by miR-181b overexpressing M s exposed to…”
BackgroundMethodSelf-citationDas, U. N. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9316-x · Cited by 49
Gene Expression Differences in Prostate Cancers between Young and Old Men
Ding, Y.-C., Wu, H., Warden, C., Steele, L., Liu, X., van Iterson, M., Wu, X., Nelson, R. A., Liu, Z., Yuan, Y., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006477 · Cited by 50
Sen, C. K. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00037.2011 · Cited by 45
PUFA diets alter the microRNA expression profiles in an inflammation rat model
Zheng, Z., Ge, Y., Zhang, J., Xue, M., LI, Q., Lin, D., & Ma, W. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3318 · Cited by 45
“Increasing evidence indicates that different PUFAs exert certain biological effects by direct miRNA modulation or via other metabolites (resolvins, lipoxins and protectins) that arise from PUFAs (36-39).”
Perucci, L. O., Sugimoto, M. A., Gomes, K. B., Dusse, L. M. S., Teixeira, M. M., & Sousa, L. P. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1364363 · Cited by 49
“Indeed, it was recently described an interesting and novel GPCR-dependent miRNA axis in resolution circuits mediated by RvD1 [133,147].”
BackgroundAspirin-triggered resolvin D1 alleviates paraquat-induced acute lung injury in mice
Hu, X., Shen, H., Wang, Y., Zhang, L., & Zhao, M. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.12.028 · Cited by 44
Livshits, G., & Kalinkovich, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102267 · Cited by 47
Roles of Resolvins in Chronic Inflammatory Response
Liu, C., Fan, D., Lei, Q., Lü, A., & He, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314883 · Cited by 45
“RvD1 can regulate miR-208a and miR-219 in macrophages to target regulating IL-10 and 5-lipoxygenase [58,75].”
BackgroundSerini, S., Vasconcelos, R. O., Fasano, E., & Calviello, G. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1139085 · Cited by 43
“mation by binding to specific receptors.[59,124] Finally, we cannot omit to mention here that impor-”
BackgroundMottola, G., Chatterjee, A., Wu, B., Chen, M., & Conte, M. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174936 · Cited by 41
Fernandes, J. C. R., Aoki, J. I., Maia Acuña, S., Zampieri, R. A., Markus, R. P., Floeter-Winter, L. M., & Muxel, S. M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00060 · Cited by 41
“miR-302d is expressed at the early time and downregulated in late time of exudate during acute inflammation inmurine peritonitis induced via TLR2/zymosan stimuli (Recchiuti et al., 2011).”
BackgroundGonzalez, A. L., Dungan, M. M., Smart, C. D., Madhur, M. S., & Doran, A. C. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0284 · Cited by 46
Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone
Fiorillo, A. A., Tully, C., Damsker, J. M., Nagaraju, K., Hoffman, E. P., & Heier, C. R. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00134.2017 · Cited by 40
Shi, Y., Dai, S., Qiu, C., Wang, T., Zhou, Y., Xue, C., Yao, J., & Xu, Y. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0216-7 · Cited by 45
Novel findings in pain processing pathways: implications for miRNAs as future therapeutic targets
Kynast, K. L., Russe, O. Q., Geißlinger, G., & Niederberger, E. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.34 · Cited by 44
Chang, M. I., Puder, M., & Gura, K. M. (2012) · Nutrients · doi:10.3390/nu4121828 · Cited by 45
“, acute lung injury, peritonitis, acute kidney injury, postoperative pain, and retinopathy) [50–55].”
BackgroundMolecular Targets of Omega 3 and Conjugated Linoleic Fatty Acids – “Micromanaging” Cellular Response
Visioli, F., Giordano, E., Nicod, N. M., & Dávalos, A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00042 · Cited by 40
Modulation of microRNAs by aspirin in cardiovascular disease
Paseban, M., Marjaneh, R. M., Banach, M., Riahi, M. M., Bo, S., & Sahebkar, A. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.08.005 · Cited by 40
“…which then downregulated PDCD4, a proinflammatory 260 regulatory protein acting both as an IL-10 inhibitor and a promoter of the NF-κB pathway 261 (Recchiuti et al., 2011) along with upregulation of miR-219 targets 5-lipoxygenase and regulates 262 leukotriene B4 production (Recchiuti et al., 2011).”
BackgroundResolvin D2 decreases TLR4 expression to mediate resolution in human monocytes
Croasdell, A., Sime, P. J., & Phipps, R. P. (2016) · The FASEB Journal · doi:10.1096/fj.201600375r · Cited by 39
Micro RNA s in neutrophils: potential next generation therapeutics for inflammatory ailments
Gurol, T., Zhou, W., & Deng, Q. (2016) · Immunological Reviews · doi:10.1111/imr.12450 · Cited by 39
Lipid mediators and asthma: Scope of therapeutics
Monga, N., Sethi, G. S., Kondepudi, K. K., & Naura, A. S. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113925 · Cited by 40
Resolvins: Endogenously-Generated Potent Painkilling Substances and their Therapeutic Perspectives
Yoo, S., Lim, J. Y., & Hwang, S. W. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311060009 · Cited by 44
“In peritonitis, RvD1 regulated microRNA (miRNA) expression [42].”
BackgroundLipoxin A 4 stimulates endothelial miR‐126–5p expression and its transfer via microvesicles
Codagnone, M., Recchiuti, A., Lanuti, P., Pierdomenico, A. M., Cianci, E., Patruno, S., Mari, V. C., Simiele, F., Tomo, P. D., Pandolfi, A., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600952r · Cited by 39
Self-citationBeyond leukotriene formation—The noncanonical functions of 5-lipoxygenase
Häfner, A., Kahnt, A. S., & Steinhilber, D. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.03.003 · Cited by 39
MicroRNAs in shaping the resolution phase of inflammation
Naqvi, R. A., Gupta, M., George, A., & Naqvi, A. R. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.03.019 · Cited by 36
Effect of aging on microRNAs and regulation of pathogen recognition receptors
Olivieri, F., Procopio, A. D., & Montgomery, R. R. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.03.006 · Cited by 34
“, miR-146b targeting NF-κB signalling and reducing protein levels of proinflammatory IL-8 and RANTES, miR-219 targeting 5-lipoxygenase and reducing leukotriene production, and miR-21 increasing anti-inflammatory IL-10 in response to LPS and promoting cell survival and proliferation by acting simultaneously on both pro…”
BackgroundZahradka, P. C., Neumann, S., Aukema, H. M., & Taylor, C. G. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.04.009 · Cited by 33
Nandivada, P., Cowan, E. A., Carlson, S. J., Chang, M. I., Gura, K. M., & Puder, M. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.02.008 · Cited by 37
Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis
Zahoor, I., & Giri, S. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08796-4 · Cited by 39
Omics Technology for the Promotion of Nutraceuticals and Functional Foods
Pandita, D., & Pandita, A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.817247 · Cited by 35
Wang, J., & Gui, Y. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/510208 · Cited by 37
Nie, X., Zhao, J., Ling, H., Deng, Y., Li, X., & He, Y. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15139 · Cited by 34
Wales, K. M., Kavazos, K., Nataatmadja, M. I., Brooks, P. R., Williams, C., & Russell, F. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112816 · Cited by 31
MicroRNA Involved in Inflammation: Control of Eicosanoid Pathway
Ochs, M. J., Steinhilber, D., & Suess, B. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00039 · Cited by 31
“Based on these data the authors create networks of target genes of RvD1-regulated miRNAs (Recchiuti et al., 2011).”
BackgroundMethodInfluentialPro-Resolving Ligands Orchestrate Phagocytosis
Decker, C., Sadhu, S., & Fredman, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660865 · Cited by 38
Self-citationObesity, immunomodulation and chronic kidney disease
Börgeson, E., & Sharma, K. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.011 · Cited by 32
“Indeed, RvD1 has been shown to promote resolution of acute inflammation via activation of microRNA [26 ] and similarly LipoxinA4 (LXA4) attenuates chronic renal inflammation by activation of let7 [27].”
BackgroundMicroRNA 21 in tissue injury and inflammation: AUTHORS' RETROSPECTIVE
Sen, C. K., & Roy, S. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs222 · Cited by 30
“miR-21 is inducible by resolvin D1 and may play a role in resolving acute inflammation.(31) PDCD4 has pro-inflamma-”
BackgroundPseudorabies viral replication is inhibited by a novel target of miR-21
Huang, J., Ma, G., Fu, L., Jia, H., Zhu, M., Li, X., & Zhao, S. (2014) · Virology · doi:10.1016/j.virol.2014.03.032 · Cited by 29
Quenching the fires: Pro-resolving mediators, air pollution, and smoking
Thatcher, T. H., Woeller, C. F., McCarthy, C. E., & Sime, P. J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.001 · Cited by 30
D‐series Resolvins activate Phospholipase D in phagocytes during inflammation and resolution
Ganesan, R., Henkels, K. M., Shah, K. N., de la Rosa, X., Libreros, S., Cheemarla, N. R., Serhan, C. N., & Gómez-Cambronero, J. (2020) · The FASEB Journal · doi:10.1096/fj.201903025rr · Cited by 32
Self-citationBuchheit, T., Huh, Y., Breglio, A. M., Bang, S., Xu, J., Matsuoka, Y., Guo, R., Bortsov, A. V., Reinecke, J., Wehling, P., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.04.013 · Cited by 29
Understanding Resolvin Signaling Pathways to Improve Oral Health
Keinan, D., Leigh, N. J., Nelson, J. W., Oleo, L. D., & Baker, O. J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14035501 · Cited by 31
“RvD1-miRNAs identified here were able to target cytokines and proteins involved in the immune system, for instance, miR-146b targeted NF-κB signaling [94].”
BackgroundInfluentialZhang, T., Xiu, H., Liu, J., Ma, Y., Xu, K.-Q., & Huang, W. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.08.008 · Cited by 28
“In addition, it has been reported that during self-limited acute inflammatory, RvD1 up-regulated microRNA-146b (miR-146b) [14], which has been shown to inhibit TNF receptor-associated factor 6 (TRAF6) expression in human umbilical vein endothelial cells [15].”
BackgroundResolution of inflammation: Intervention strategies and future applications
Panezai, J., & Dyke, T. E. V. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116089 · Cited by 33
Immunoresolvents signaling molecules at intersection between the brain and immune system
Dalli, J., & Serhan, C. N. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.10.007 · Cited by 30
“Several mechanisms are now implicated in the regulation of SPM biosynthesis; regulation of micro RNA 219 controls 5-LOX expression [24].”
BackgroundSelf-citationMolecular Pharmacology of Inflammation Resolution in Atherosclerosis
Kotlyarov, S. N., & Котлярова, А. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094808 · Cited by 34
“The main role of the receptor is to enhance phagocytosis, reduce PMN infiltration [168,169], and participate in the processes of inflammation resolution [61,170,171].”
BackgroundThe roles of special proresolving mediators in pain relief
Lan-yu, Z., Jia, M., & Sun, T. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0074 · Cited by 29
Resolvins RvD1 and 17(R)-RvD1 alleviate signs of inflammation in a rat model of endometriosis
Dmitrieva, N., Suess, G., & Shirley, R. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.06.046 · Cited by 28
Wu, D., Zheng, S., Li, W., Yang, L., Liu, Y., Zheng, X., Yang, Y., Yang, L.-M., Wang, Q., Smith, F. G., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/964012 · Cited by 28
“Resolvin D1 has recently been identified to inhibit PMN infiltration and transmigration [18–20], reduce interstitial fibrosis [21], regulate cytokines to sites of inflammation [22, 23], and protect after ischemia-reperfusion second organ injury [21, 24] and LPS-induced acute lung injury [25].”
BackgroundPolyunsaturated Fatty Acid Metabolism in the Brain and Brain Cells
Joffre, C. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88232 · Cited by 34
Trotta, M. C., Pieretti, G., Petrillo, F., Alessio, N., Hermenean, A. O., Maisto, R., & D’Amico, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29303 · Cited by 26
Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
Recchiuti, A., Isopi, E., Romano, M., & Mattoscio, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186637 · Cited by 27
“cells(NF-κB) [90] and Nrf-2 [18] activation, modulate the ERK, EGFR, and mTOR pathways [91], and regulate the expression of inflammatory microRNAs (miRNAs) [92].”
BackgroundSelf-citationChiang, N., de la Rosa, X., Libreros, S., Pan, H., Dreyfuss, J. M., & Serhan, C. N. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013374118 · Cited by 24
“For example, RvD1 regulates specific miRNAs that target NF-κB pathways (TRAF6, NOS2), pathogen recognition (TLRs, CD1d), leukocyte activation (CD40, PAFR), as well as IL-1 family and receptors (IL-1R, IL-1RA) (65).”
BackgroundSelf-citationInflammatory microRNAs in cardiovascular pathology: another brick in the wall
Zapata-Martínez, L., Águila, S., Reyes‐García, A. M. D. L., Carrillo‐Tornel, S., Lozano, M. L., Gónzález‐Conejero, R., & Martínez, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1196104 · Cited by 28
The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease
Briottet, M., Shum, M., & Urbach, V. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01290 · Cited by 26
“Of note, RvD1 contributes to resolving inflammation by regulating a set of microRNAs specific to each receptor, FPR2 and GPR32 (Krishnamoorthy et al., 2010; Recchiuti et al., 2011).”
BackgroundInfluentialResolution of chronic inflammation and cancer
Tezcan, G., Yakar, N., Hastürk, H., Dyke, T. E. V., & Kantarcı, A. (2024) · Periodontology 2000 · doi:10.1111/prd.12603 · Cited by 34
Taoro‐González, L., Pereda, D., Valdés‐Baizabal, C., González‐Gómez, M., Pérez, J. A., Mesa-Herrera, F., Canerina‐Amaro, A., Perez-Gonzalez, H., Rodríguez, C., Díaz, M. L., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137430 · Cited by 28
“Hippocampal levels of IL-1β and TNF-α are differentially modulated by age and an n-3 LCPUFA-enriched diet.”
BackgroundInfluentialAre miRNAs critical determinants in herpes simplex virus pathogenesis?
Bhela, S., & Rouse, B. T. (2017) · Microbes and Infection · doi:10.1016/j.micinf.2017.12.007 · Cited by 23
“For example, miR-219 targets 3′ UTR of 5-lipoxygenase (enzyme required for the biosynthesis of lipoxins) and reduces leukotriene B4 while increasing SPM production [57].”
BackgroundInfluentialFußbroich, D., Kohnle, C., Schwenger, T., Drießler, C., Duecker, R. P., Eickmeier, O., Gottwald, G., Jerkic, S., Zielen, S., Kreyenberg, H., et al. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106378 · Cited by 22
Kilpinen, L., Parmar, A., Greco, D., Korhonen, M. O., Lehenkari, P. P., Saavalainen, P., & Laitinen, S. (2016) · Aging · doi:10.18632/aging.101088 · Cited by 22
“Of these miRNAs, miR-21 is highly expressed in MSCs and its expression has been shown to be induced by an antiinflammatory lipid molecule, resolvin D1, which participates in the attenuation of the inflammatory response [32].”
Kang, G.-J., Lee, H.-J., Byun, H. J., Kim, E. J., Kim, H. J., Park, M. K., & Lee, C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.01.006 · Cited by 26
Dufour, D., Khalil, A., Nuyens, V., Rousseau, A., Delporte, C., Noyon, C., Cortese, M., Reyé, F., Pireaux, V., Nève, J., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.03.012 · Cited by 22
Li, H., Fang, Q., Zhang, P., & Shao, Y. (2021) · Human & Experimental Toxicology · doi:10.1177/09603271211035665 · Cited by 23
Causes and Consequences of MicroRNA Dysregulation Following Cerebral Ischemia-Reperfusion Injury
Forouzanfar, F., Shojapour, M., Asgharzade, S., & Amini, E. (2019) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527318666190204104629 · Cited by 26
Kumar, V., Yasmeen, N., Chaudhary, A. A., Alawam, A. S., Al-Zharani, M. M., Basher, N. S., Harikrishnan, S., Goud, M. D., Pandey, A., Lakhawat, S. S., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1104577 · Cited by 23
“Furthermore, SPMs decrease the release of pro-inflammatory chemical mediators, whilst increase the anti-inflammatory mediators such as IL-10, thereby reduces both cytokine and eicosanoid storms (Schif-Zuck et al., 2011; Titos et al., 2016; Recchiuti et al., 2011).”
BackgroundSolano-Aguilar, G. I., Molokin, A., Botelho, C. A., Fiorino, A., Vinyard, B. T., Li, R., Chen, C. T., Urban, J. F., Dawson, H. D., Andreyeva, I., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147426 · Cited by 23
“This tool predicted upstream regulators and inferred their activation state by calculating a Z-score to assess the match of observed and predicted up/down regulation patterns.”
BackgroundInfluentialAltered microRNA expression profiles in lung damage induced by nanosized SiO2
Hong, Y., Zhang, Y., Li, W., Lao, C., Li, M., & Zheng, Y. (2016) · Bioengineered · doi:10.1080/21655979.2016.1227578 · Cited by 21
The utilisation of resolvins in medicine and tissue engineering
Blaudez, F., Ivanovski, S., Fournier, B., & Vaquette, C. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.11.047 · Cited by 19
The effect of polyunsaturated fatty acids on obesity through epigenetic modifications
Boigues, J. F. H., & Mach, N. (2015) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2015.08.003 · Cited by 22
Role of MicroRNA in Visceral Pain
Zhang, J., & Banerjee, B. (2015) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15027 · Cited by 23
MicroRNA Function in the Profibrogenic Interplay upon Chronic Liver Disease
Huang, J., Yu, X., Fries, J. W. U., Zhang, L., & Odenthal, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069360 · Cited by 21
“regulation is also an important feature in acute and chronic inflammatory diseases [9–12].”
Resolvin D1 attenuates the inflammatory process in mouse model of LPS‐induced keratitis
Petrillo, F., Trotta, M. C., Bucolo, C., Hermenean, A. O., Petrillo, A., Maisto, R., Pieretti, G., Pietropaolo, M., Ferraraccio, F., Gagliano, C., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15633 · Cited by 19
Boigues, J. F. H., & Mach, N. (2015) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2015.03.009 · Cited by 19
Shi, H., Carion, T. W., Jiang, Y., Steinle, J. J., & Berger, E. A. (2016) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2016.03.001 · Cited by 18
Kendirlioglu, B. K., Özperçin, P. Ü., Yüksel, Ö., Sözen, Ş., Cihnioğlu, R., Kalelioğlu, T., İlnem, M. C., & Karamustafalıoğlu, N. (2019) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2019.1673480 · Cited by 19
“In Fpr2 knockouts, RvD1 had no effect on leukocyte infiltration, did not control miRNAs, and did not increase IL-10 expression [23].”
BackgroundBhat, T. A., Kalathil, S. G., Bogner, P. N., Lehmann, P., Thatcher, T. H., Sime, P. J., & Thanavala, Y. M. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001228 · Cited by 18
Resolvins Lipid Mediators: Potential Therapeutic Targets in Alzheimer and Parkinson Disease
Anand, S., Ansari, M. A., Sukrutha, S. K., Alomary, M. N., Khan, A. A., & Elderdery, A. Y. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.11.001 · Cited by 17
Immunomodulation of periodontitis with SPMs
Sahni, V., & Dyke, T. E. V. (2023) · Frontiers in Oral Health · doi:10.3389/froh.2023.1288722 · Cited by 22
Fukuishi, N., Takahama, K., Kurosaki, H., Ono, S., & Asai, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041491 · Cited by 18
Barnett, R. E., Keskey, R. C., Rao, J. M., Billeter, A. T., Kanaan, Z. M., & Cheadle, W. G. (2013) · Surgery · doi:10.1016/j.surg.2013.06.048 · Cited by 17
Metadata
- Authors
- Recchiuti, A., Krishnamoorthy, S., Fredman, G., Chiang, N., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Serhan, Charles N.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2010-10-18
- Volume
- 25
- Issue
- 2
- Pages
- 544-560
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3023392
- OpenAlex
- W2039265368
- Cited by
- 292
- References
- 51
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 13 · 2023: 10 · 2022: 15 · 2021: 18 · 2020: 25 · 2019: 25 · 2018: 18 · 2017: 21 · 2016: 16 · 2015: 17 · 2014: 25 · 2013: 31 · 2012: 26
- FWCI
- 22.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R37GM38765, R01DK074448, R01DE019938)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- microRNA, inflammation resolution, resolvin D1, acute inflammation, peritonitis, miR-146b, miR-21, miR-219, miR-208a, zymosan, neutrophil infiltration, FPR2/ALX, NF-κB signaling, 5-lipoxygenase, leukotriene biosynthesis, Smad, macrophages
- MeSH terms
- Acute Disease, Animals, Docosahexaenoic Acids, Gene Expression Regulation, Inflammation, Peritonitis, Recombinant Proteins, Zymosan, Polymerase Chain Reaction, MicroRNAs, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.